141 related articles for article (PubMed ID: 29513966)
1. STUDY OF OFLOXACIN ENANTIOMERS DISSOLUTION FROM SELECTED SOLID DOSAGE FORMS USING HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS METHOD.
Urbaniak B; Milanowski B; Lulek J; Kokot ZJ
Acta Pol Pharm; 2017 May; 74(3):955-968. PubMed ID: 29513966
[TBL] [Abstract][Full Text] [Related]
2. Correlation of dissolution and disintegration results for an immediate-release tablet.
Nickerson B; Kong A; Gerst P; Kao S
J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
[TBL] [Abstract][Full Text] [Related]
3. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
4. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
5. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
Shibata H; Yoshida H; Izutsu K; Goda Y
J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of the enantiomers of ofloxacin by capillary electrophoresis in the parts per billion concentration range for in vitro drug absorption studies.
Awadallah B; Schmidt PC; Wahl MA
J Chromatogr A; 2003 Feb; 988(1):135-43. PubMed ID: 12647828
[TBL] [Abstract][Full Text] [Related]
7. Photoreactivity of biologically active compounds. XVIII. Photostability of ofloxacin in the solid state and in a tablet formulation.
Tønnesen HH; Brunsvik A; Løseth K; Bergh K; Gederaas OA
Pharmazie; 2007 Feb; 62(2):105-11. PubMed ID: 17341028
[TBL] [Abstract][Full Text] [Related]
8. DISSOLUTION KINETICS STUDIES OF CLOPIDOGREL FROM SELECTED MULTISOURCE COATED TABLETS WITH APPLICATION OF CAPILLARY ZONE ELECTROPHORESIS METHOD.
Karaźniewicz-Łada M; Milanowski B; Lulek J; Główka F
Acta Pol Pharm; 2016; 73(1):197-207. PubMed ID: 27008814
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro evaluation of ofloxacin-ethocel controlled release matrix tablets prepared by wet granulation method: influence of co-excipients on drug release rates.
Shah S; Shah K; Jan SU; Ahmad K; Rehman A; Hussain A; Khan GM
Pak J Pharm Sci; 2011 Jul; 24(3):255-61. PubMed ID: 21715257
[TBL] [Abstract][Full Text] [Related]
10. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
11. Studies of variability in dissolution testing with USP apparatus 2.
Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
[TBL] [Abstract][Full Text] [Related]
13. Biowaiver monographs for immediate release solid oral dosage forms: levofloxacin.
Koeppe MO; Cristofoletti R; Fernandes EF; Storpirtis S; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Dressman JB; Barends DM
J Pharm Sci; 2011 May; 100(5):1628-36. PubMed ID: 21374601
[TBL] [Abstract][Full Text] [Related]
14. Terbium-sensitized luminescence determination of levofloxacin in tablets and human urine and serum.
Ocaña JA; Callejón M; Barragán FJ
Analyst; 2000 Oct; 125(10):1851-4. PubMed ID: 11070553
[TBL] [Abstract][Full Text] [Related]
15. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
16. NEW METHODOLOGY FOR DEVELOPMENT OF ORODISPERSIBLE TABLETS USING HIGH-SHEAR GRANULATION PROCESS.
Ali BE; Al-Shedfat RI; Fayed MH; Alanazi FK
Acta Pol Pharm; 2017 May; 74(3):969-981. PubMed ID: 29513967
[TBL] [Abstract][Full Text] [Related]
17. Enantioselective analysis of ofloxacin and ornidazole in pharmaceutical formulations by capillary electrophoresis using single chiral selector and computational calculation of their inclusion complexes.
Al Azzam KM; Saad B; Adnan R; Aboul-Enein HY
Anal Chim Acta; 2010 Aug; 674(2):249-55. PubMed ID: 20678638
[TBL] [Abstract][Full Text] [Related]
18. Multivariate approaches for the development of quality control in-situ fiber optics dissolution methods for fixed-dose combination tablets.
Medendorp J; Colón I; Ryan T
Drug Dev Ind Pharm; 2019 Jun; 45(6):999-1008. PubMed ID: 30905176
[TBL] [Abstract][Full Text] [Related]
19. High performance capillary electrophoresis for determination of the enantiomers of 2-arylpropionic acid derivatives in human serum. Pharmacokinetic studies of ketoprofen enantiomers following administration of standard and sustained release tablets.
Główka FK; Karaźniewicz M
J Pharm Biomed Anal; 2004 Jun; 35(4):807-16. PubMed ID: 15193725
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of ofloxacin and ornidazole in pharmaceutical preparations by capillary zone electrophoresis.
See KL; Elbashir AA; Saad B; Ali AS; Aboul-Enein HY
Biomed Chromatogr; 2009 Dec; 23(12):1283-90. PubMed ID: 19488980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
